Drug Profile
Piclamilast
Alternative Names: Piclamast; RP 73401; RPR 73401Latest Information Update: 17 Dec 2003
Price :
$50
*
At a glance
- Originator Aventis
- Class Benzamides; Pyridines; Small molecules
- Mechanism of Action Tumour necrosis factor inhibitors; Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Dermatitis; Rheumatoid arthritis
- Discontinued Asthma